MRC1 and Lynch syndrome: In this report, we retrospectively investigated patients in whom the pathogenic variant of MMR gene was detected by CGP, and we aim to demonstrate the potential of CGP as a complementary screening strategy for Lynch syndrome, particularly in patients who would otherwise be missed by conventional clinical screening, MSI testing, or MMR immunohistochemistry.